Biodegradable Long Acting Injectables and Implants An Industry View /
Long acting injectables and implants (LAI) are known to improve patient adherence and treatment outcomes. They reduce costs for the healthcare system and ensure sustainable sales for pharmaceutical companies. LAI are usually administered intramuscularly (IM) or subcutaneously (SC). In this way, the...
Furkejuvvon:
| Searvvušdahkki: | |
|---|---|
| Eará dahkkit: | |
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2025.
|
| Preanttus: | 1st ed. 2025. |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1007/978-3-031-72302-5 |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Sisdoallologahallan:
- Preface
- Drug design for the development of long acting injectables
- Biodegradable polymers for development of LAI
- A roadmap for production of drug loaded poly (lactic-co-glycolic acid) (PLGA) microparticles: challenges and opportunities
- Biodegradable in situ forming and preformed implants
- Suspension-Based Long Acting Injectables
- Oil based solutions
- Clinical applications of LAI: systemic and local drug delivery
- Local Tolerability of Long-acting Injectables
- Envisaging the future.